XM does not provide services to residents of the United States of America.
E
E

EastmanChemical


News

U.S. STOCKS Albertsons, Foot Locker, Charles Schwab

BUZZ-U.S. STOCKS ON THE MOVE-Albertsons, Foot Locker, Charles Schwab Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street slipped on Tuesday, with the tech-heavy Nasdaq leading the decline, as a slump in semiconductor and oil stocks offset strong quarterly results from major banks.
C
C
M
L
A
U
U
U
S
A
A
E

U.S. STOCKS Albertsons, Foot Locker, Charles Schwab

BUZZ-U.S. STOCKS ON THE MOVE-Albertsons, Foot Locker, Charles Schwab Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the Nasdaq edged higher while the Dow dropped on Tuesday, with the benchmark index hovering near record highs as investors parsed a mixed set of quarterly results from companies such as UnitedHealth and Bank of America.
A
A
B
C
C
G
I
M
N
W
L
A
K
L
R
U
U
U
S
A
A
E

U.S. STOCKS U.S. airlines, Citigroup, Bank of America

BUZZ-U.S. STOCKS ON THE MOVE-U.S. airlines, Citigroup, Bank of America Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Oct 15 (Reuters) - Futures pointed to a subdued open for Wall Street's main indexes on Tuesday, as investors took a breather after a rally in the previous session and parsed a mixed set of quarterly results from companies such as UnitedHealth and Bank of America.
A
B
C
C
C
G
W
A
U
U
S
A
A
E

U.S. STOCKS Johnson & Johnson, Boeing, Wolfspeed

BUZZ-U.S. STOCKS ON THE MOVE-Johnson & Johnson, Boeing, Wolfspeed Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 U.S. stock index futures were subdued on Tuesday as investors took a breather after a rally in the previous session and assessed quarterly results from companies including Bank of America and UnitedHealth.
A
B
C
C
G
W
U
S
A
E

Wells Fargo raises PT on US chemical firms

BUZZ-Wells Fargo raises PT on US chemical firms ** Wells Fargo raises price target on chemical companies Avient Corp AVNT.N , Eastman Chemical Company EMN.N and Sherwin-Williams SHW.N ** Says that it remains positive on the chemicals sector as odds of a macro recovery over the next 12 months appear improved given U.S. Fed rate cuts and China stimul
S
E

RBC Capital Markets sees dour Q3 for chemical commodity companies

BUZZ-RBC Capital Markets sees dour Q3 for chemical commodity companies ** RBC Capital Market's earnings expectations for commodity chemical companies in second half of 2024 have come down further due to ongoing Europe weakness and unplanned outages through Q3 ** While businesses and consumer demand could improve on interest rate cuts, benefits not
D
C
E

U.S. ANI Pharmaceuticals, Deere & Co, Zoetis

U.S. RESEARCH ROUNDUP-ANI Pharmaceuticals, Deere & Co, Zoetis Oct 11 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ANI Pharmaceuticals, Deere & Co and Zoetis, on Friday. HIGHLIGHTS * ANI Pharmaceuticals Inc ANIP.O : Piper Sandler initiates coverage with overweight rating * Deere & Co DE.N : JP Morgan raises target price to $420 from $360 * Northrop Grumman NOC.N : Citigroup raises target price to $587 from $521 * S
A
C
G
H
I
A
C
F
A
C
A
A
C
C
C
E

U.S. Fox Corp, Smartsheet, Tesla

U.S. RESEARCH ROUNDUP-Fox Corp, Smartsheet, Tesla Sept 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Fox Corp, Smartsheet and Tesla, on Wednesday. HIGHLIGHTS * Fortrea Holdings Inc FTRE.O : Jefferies cuts to hold from buy * Fox Corp FOXA.O : CFRA cuts to sell from hold * Hewlett Packard Enterprise CO HPE.N : Barclays raises to overweight from equal-weight * Smartsheet Inc SMAR.N : D.A.
A
H
N
N
T
F
G
E
M

Eastman Announces Tender Offer Pricing For 3.8% Notes Due 2025

BRIEF-Eastman Announces Tender Offer Pricing For 3.8% Notes Due 2025 Aug 12 (Reuters) - Eastman Chemical Co EMN.N : EASTMAN CHEMICAL COMPANY ANNOUNCES PRICING OF TENDER OFFER FOR 3.800% NOTES DUE 2025 Source text for Eikon: ID:nBw5Y71tXa Further company coverage: EMN.N
E

U.S. Alexander & Baldwin, Instructure Holdings, RPM International

U.S. RESEARCH ROUNDUP-Alexander & Baldwin, Instructure Holdings, RPM International July 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alexander & Baldwin, Instructure Holdings and RPM International, on Friday. HIGHLIGHTS * Alexander & Baldwin Inc (Hawaii) ALEX.N : Piper Sandler raises to overweight from neutral * First Financial Northwest Inc FFNW.O : Piper Sandler cuts to neutral from overweight * Instructure H
C
D
H
I
A
D
E
A
A
C
E
G

Eastman Chemical Co reports results for the quarter ended in June - Earnings Summary

Eastman Chemical Co reports results for the quarter ended in June - Earnings Summary Eastman Chemical Co EMN.N reported quarterly adjusted earnings of $2.15​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.99. The mean expectation of nineteen analysts for the quarter was for earnings of $2.01 per share.
E

Eastman Chemical beats quarterly profit estimates on higher sales

Eastman Chemical beats quarterly profit estimates on higher sales July 25 (Reuters) - Eastman Chemical EMN.N beat Wall Street estimates for second-quarter profit on Thursday, as the diversified chemicals company benefited from higher sales volumes. Shares of the company were up 2.3% in extended trading. "Through this year, we are benefiting from the end of destocking, as our volumes have reconnected to underlying demand," said CEO Mark Costa.
E

Eastman Chemical Q2 Adjusted EPS USD 2.15 Vs. IBES Estimate USD 2.01

BRIEF-Eastman Chemical Q2 Adjusted EPS USD 2.15 Vs. IBES Estimate USD 2.01 Jul 25 (Reuters) - Eastman Chemical Q2 EPS USD 1.94. Q2 revenue USD 2,363 million vs. IBES estimate USD 2,358 million Q2 EBIT USD 337 million Q2 adjusted EBIT USD 353 million vs. IBES estimate USD 332 million
E

Growth angst or air pocket? Stocks nurse losses

MORNING BID AMERICAS-Growth angst or air pocket? Stocks nurse losses A look at the day ahead in U.S. and global markets from Mike Dolan The worst day for the S&P500 .SPX since 2022 and mounting central bank easing bets suggest markets' serene 'soft landing' scenario is being questioned as China growth worries and U.S. election risks mount. Even though a withering swoon in megacap tech stocks this week comes in the thick of the corporate earnings season, the incoming aggregate profit growth pictu
G
G
H
K
L
N
P
U
V
V
A
G
J
U
U
U
F
E



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.